Technical Analysis for INSM - Insmed, Inc.

Grade Last Price % Change Price Change
grade F 18.82 -1.00% -0.19
INSM closed down 1.0 percent on Friday, September 13, 2019, on 58 percent of normal volume. It ran into resistance at its 50 day moving average. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical INSM trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Weak + Overbought Other 0.00%
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
50 DMA Resistance Bearish -1.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.00%
Upper Bollinger Band Walk Strength -1.00%

Older signals for INSM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing targeted inhalation therapies for patients battling serious lung diseases. Its lead candidate ARIKACE is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the treatment for two identified patient populations comprising cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). The company's Phase III registrational study of ARIKACE in CF patients in Europe and Canada has completed enrollment; and Phase II clinical trial in NTM patients is under way with clinical results. Insmed Incorporated was founded in 1999 and is headquartered in Monmouth Junction, New Jersey.
Biopharmaceutical Medical Specialties Infectious Diseases Cystic Fibrosis Infectious Causes Of Cancer Microbiology Bacterial Diseases Bacteriology Pseudomonas Tuberculosis Mycobacterium Nontuberculous Mycobacteria
Is INSM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 33.13
52 Week Low 11.31
Average Volume 1,180,184
200-Day Moving Average 23.5529
50-Day Moving Average 19.0422
20-Day Moving Average 17.026
10-Day Moving Average 17.609
Average True Range 0.9056
ADX 29.58
+DI 28.6541
-DI 13.9634
Chandelier Exit (Long, 3 ATRs ) 16.7032
Chandelier Exit (Short, 3 ATRs ) 18.0468
Upper Bollinger Band 19.0478
Lower Bollinger Band 15.0042
Percent B (%b) 0.94
BandWidth 23.749559
MACD Line -0.0013
MACD Signal Line -0.5143
MACD Histogram 0.513
Fundamentals Value
Market Cap 1.17 Billion
Num Shares 62.4 Million
EPS -3.04
Price-to-Earnings (P/E) Ratio -6.19
Price-to-Sales 0.00
Price-to-Book 20.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.83
Resistance 3 (R3) 19.89 19.61 19.66
Resistance 2 (R2) 19.61 19.36 19.58 19.60
Resistance 1 (R1) 19.22 19.20 19.08 19.16 19.55
Pivot Point 18.94 18.94 18.88 18.91 18.94
Support 1 (S1) 18.55 18.69 18.41 18.49 18.09
Support 2 (S2) 18.27 18.53 18.24 18.04
Support 3 (S3) 17.88 18.27 17.98
Support 4 (S4) 17.82